Malaria and Medical Cannabis

Malaria (swamp fever) is the world's most common infectious disease caused by parasites, affecting over 200 million people worldwide. There are several malaria pathogens that are spread in different areas. The World Health Organisation (WHO) distinguishes the following areas: Areas without a malaria risk: Europe, Australia, North America, Sri Lanka Areas with a low risk [...]

Alzheimer’s disease and medical cannabis

The neurodegenerative Alzheimer's disease is the most common form of dementia, which usually occurs in people over the age of 65. About 24 million people worldwide suffer from this disease, which is named after the physician Alois Alzheimer. He first described the disease in 1906. Alzheimer's: What happens in the brain? In Alzheimer's patients, nerve [...]

Restless Legs Syndrome: Medical cannabis as a therapy option

People with restless legs syndrome (RLS) complain of a strong urge to move their legs at night. Mostly also about tingling and aching legs. This is known as restless legs syndrome (RLS), a frequently occurring neurological disease. The study situation regarding the therapy with medical cannabis for movement disorders is not yet clear. However, the [...]

Can cannabidiol replace antibiotics?

The therapeutic potential of cannabis has called the scientific community’s attention, who in the last decades have intensified their researches to reveal the secrets of this plant.  Especially everything related to cannabidiol (CBD). This non-psychoactive cannabinoid from cannabis is considered one of the most interesting components by many scientists.  It has many properties which [...]

Cannabinoids and Dystonia

Dystonia is a neurological movement disorder syndrome in which involuntary repetitive muscle contractions and spasms result in abnormal fixed postures or twisting. It can affect only one muscle, a group of muscles or even the entire body. It is believed to affect 1 % of the world’s population and it has been found to be [...]

The DEA includes a cannabidiol-based medicine in the Controlled Substances Act

On Thursday 27th of September, Epidiolex became the first cannabidiol-based substance placed under Schedule V of the Controlled Substances Act (CSA) by the Department of Justice and Drug Enforcement Administration (DEA). This was the consequence of a large, controlled and successful clinical trial that led the DEA to accept the medical application of this CBD-based [...]

New findings on the effect of cannabis on HIV

The human immunodeficiency virus (HIV) affects about 36 million people worldwide. The disease, which is transferred by contact with body fluids (e.g. blood, sperm and vaginal secretion), shows the destruction of the cells of the immune system. Since the discovery in the 1980s, there have been about 35 million people that died. The fact that [...]

Ulcerative colitis: Medical cannabis as a complementary form of therapy?

The intestine is a fascinating organ. It's approximately seven meters long in adult humans and fulfils not only digestive but also a number of other important functions. For example, it plays an essential role for the immune defense, since 70 % of all immune cells are located in the small and large intestine and 80 [...]

CBD and Sciatica

Sciatica is the name given to a set of symptoms that arise from nerve pain, localised to the sciatic nerve. The sciatic nerve is the longest nerve in the whole body, running from the end of the spinal cord in the lower back, splitting down both legs and ending at the feet. When something causes [...]

The effects of CBD and THC on weight loss

Why is it that people who consume marijuana regularly, "stoners", are always portrayed as skinny even though smoking marijuana is known to increase ones appetite, normally known as "the munchies"?[1] It is a stereotype however there are some truths behind it. On average, people who consume marijuana regularly have a lower BMI and a smaller [...]

CENTRAL OFFICE LOCATION

Kalapa Clinic S.L.
B66397506
Gran de Gràcia 15 , 1º.1ª
08012. Barcelona. Spain.
Tel: +34 630 109 176
Email: info@kalapa-clinic.com